A Phase 2 interventional study of Sodium Lactate and 3% NaCl in Septic Shock and Intracranial Hypertension, sponsored by University Hospital Pilsen. Recruiting at 1 site in Czechia. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-04-14.
Sponsored by University Hospital Pilsen · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in Shock, Septic with a site in Czechia — 2 open to participants now, 2 under way, none of them phase 3. Shock, Septic · Czechia.
Among the 19 studies in Shock, Septic with a site in Czechia, this one is the 10th largest by planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2024, is one of 3 in phase 2, and was the 19th registered.
1,084 studies on the registry are indexed under Shock, Septic; 236 are open to participants now.
Browse Shock, Septic studies →2 of the 19 studies in Shock, Septic with a site in Czechia are open now. Recruiting first, the newest first:
Charles University, Czech Republic · Sites in Czechia
Ages 18+ · Healthy volunteers
A study can be open while its sites in Czechia have not opened yet or have stopped. Only those recruiting at a site in Czechia →
Of the 137 Shock, Septic studies recruiting now, 103 (75%) set no upper age limit and 18 (13%) stop at 75 or younger; 11 take children under 18; 14 take healthy volunteers.
This study: 18 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 1 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 78 across 639 interventional studies indexed under Shock, Septic.
Median enrollment 277 across the 11 interventional studies, 95 across the 8 observational. Of the 13 that completed or were terminated, 4 (31%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 19 have an industry lead sponsor. The 10 most frequent:
University Hospital Pilsen is the lead sponsor of 10 studies on the registry; 7 are open to participants now.
University Hospital Pilsen has 1 study filed under Shock, Septic — fewer than ten, so there is no comparison to draw.
1 of the studies in Shock, Septic with a site in Czechia that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06634069University Hospital PilsenStudy SOLACE SEPSIS | 2027-10-31 |
Add it to your calendar (.ics) → With an account.
Among the 19 studies in Shock, Septic with a site in Czechia, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A Pilot, Randomized, Double-Blinded, Controlled Study of Hemodynamic and Acid Base Effects of 0.5M Sodium Lactate and 3% Saline Solutions in Septic Shock Patients
This study investigates two resuscitation fluids that are being used off label for the treatment of patients suffering from septic shock and also in patients with intracranial hypertension in intensive care.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Subjects will be eligible for the trial if they meet all of the following criteria:
Septic shock - Sepsis 3 criteria :
Likely need for fluid resuscitation
Exclusion Criteria:
Subjects will not be eligible for the trial if they meet any of the following criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A yellow substance made when red blood cells are broken down, which the liver clears. A high level can mean a problem with the liver or the bile ducts.
Criteria often allow more for people with Gilbert’s syndrome, a harmless inherited condition that raises bilirubin.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Bilirubin
A yellow substance made when red blood cells are broken down, which the liver clears. A high level can mean a problem with the liver or the bile ducts.
Criteria often allow more for people with Gilbert’s syndrome, a harmless inherited condition that raises bilirubin.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients suffering from septic shock who require fluid resuscitation get 0.5M HSL (containing 504mM of sodium and lactate)
Drug: Sodium Lactate
Patients suffering from septic shock who require fluid resuscitation get 3% NaCl (containing 513mM of sodium and chloride)
Drug: 3% NaCl
0.5M HSL (containing 504mM of sodium and lactate)
Also known as: 0.5M natrii lactatis
active compartor 3% NaCl
haemodynamic effects
SV is the amount of blood that leaves the left ventricle with every beat cycle and is calculated by measuring the Doppler flow in the aortic valve. Unit: ml
Time frame: at time of start of infusion, at 30 minutes and at 60 minutes from the start of the respective fluid bolus
acid-base effect
Diagnostic approach to acid-base changes is based on the assessment of bicarbonate buffer system, in which pH is determined by the ratio of \[HCO3-\] to pCO2 meassured by a POC whole-blood analyzer system Unit: \[HCO3-\] - mmol/l, pCO2 - kPa
Time frame: at time of start of infusion, at 30 minutes and at 60 minutes from the start of the respective fluid bolus
anti-inflammatory effect
Inflammatory markers as CRP, procalcitonin, interleukin-6 and feritin are sepcific indicators linked to degree of inflammation and determined by regular biochemical analysis. The dynamics of parameters after the study fluid administration will be evaluated. Unit: CRP - mg/l, procalcitonin - ug/l, interleukin-6 - ng/l, ferritin - ug/l
Time frame: parameters measured within the last 24 hours prior to start of infusion and within 24 hours after the study fluid infusion.
Safety - Incidence of adverse events and reactions
Incidence of adverse events and reactions according to following Adverse Events of Special Interest (AESI) and descriptive analysis of the incidence of any adverse events and reactions during participation in the study in both study arms. AEs are defined according to the valid definitions for clinical trials as imposed by legislation (Directive 2001/20/EG).
Time frame: 30 days after intervention
Plan to share: Undecided — Not yet decided to sharing IPD.
No publications or documents are linked to this record.
Started Nov 2024 (actual). Primary completion is estimated for Oct 2027, 35 months after the start.
Of 36 non-industry phase 2 interventional studies under Shock, Septic, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 42. This study's planned 35 months is above that.
Counting every sponsor, half of 41 studies reached it within 29 months; a quarter within 15 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Sodium Lactate
University Hospital Pilsen